Related Experiment Videos
Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?
Naftali Kaminski1, Anat Achiron
1Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. kaminskin@upmc.edu
Plos Medicine
|March 2, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Long-term efficacy of cladribine tablets: Results from the MAGNIFY-MS Extension study.
Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study.
Therapeutic advances in neurological disorders·2025
Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific Monitoring and Therapeutic Response Assessment.
Journal of the American College of Cardiology·2026
2026 Update on Clinical Trials in β-Thalassemia.
American journal of hematology·2026
Knowledgeable Language Models as Black-Box Optimizers for Personalized Medicine.
... International Conference on Learning Representations·2026
Durable LVAD therapy in end-stage methamphetamine-associated heart failure: a case report of the bridge to opportunity and transplant candidacy.
European heart journal. Case reports·2026
Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.
Frontiers in cellular and infection microbiology·2026